From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

To end the Latino HIV crisis, health programs must be developed, tailored and evolve to meet the health needs and preferences of our diverse Latino communities.

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

TV, the nation's leading Spanish-language public broadcaster, is proud to announce a partnership with South Florida PBS to ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new research data from its innovative HIV treatment ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

Marc Meachem, head of U.S. External Affairs at ViiV Healthcare, highlights factors that contribute to the disproportionate ...

Many patients with HIV have untreated anxiety symptoms, and findings show that viral suppression is worst in patients with untreated moderate-to-severe anxiety.

The Center for Global Health Practice and Impact (CGHPI) at Georgetown University Medical Center received a $27.5 million grant from the U.S. Centers for Disease Control and Prevention (CDC) and the ...

The campaign provided tips for creating a welcoming environment and printable signs that identify a practice as a stigma-free zone.

In children with HIV, whose immune systems are poor, any intervention that could inadvertently increase infection risk is ...

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...